TITLE

"Liberation" death

AUTHOR(S)
Collier, Roger
PUB. DATE
August 2011
SOURCE
CMAJ: Canadian Medical Association Journal;8/9/2011, Vol. 183 Issue 11, pE723
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the death of Canadian woman, who underwent experimental multiple sclerosis therapy called liberation treatment, developed by Italian neurologist Paolo Zamboni.
ACCESSION #
67139066

 

Related Articles

  • Combination therapy in multiple sclerosis. Conway, D.; Cohen, J. A. // Current Medical Literature: Multiple Sclerosis;2010, Vol. 2 Issue 2, p53 

    In this article the author discusses the study by D. Conway and J. A. Cohen regarding the use of combination therapy in the treatment of multiple sclerosis (MS) that targets a range of disease mechanisms.

  • Hookworms Good for MS?  // New Mobility;Jul2010, Vol. 21 Issue 202, p50 

    The article focuses on the recommendation of British-born Jasper Lawrence to use hookworms as an alternative in treating autoimmune diseases such as multiple sclerosis (MS).

  • Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Weber-Schoendorfer, C.; Schaefer, C. // Multiple Sclerosis (13524585);Sep2009, Vol. 15 Issue 9, p1037 

    Background There is still uncertainty about the management of pregnant women exposed to immunomodulatory therapy for treatment of multiple sclerosis (MS) in pregnancy. Objective To assess the safety of interferon (IFN)-�1a, IFN-�1b, and glatiramer acetate (GA) for treatment of MS...

  • Multiple myeloma, multiple sclerosis, Hashimoto's thyroiditis… An Unusually Exciting Day in Mexico. Gerson, Charlotte // Gerson Healing Newsletter;May/Jun2010, Vol. 25 Issue 3, p7 

    The article profiles patients who followed the Gerson therapy in a Mexican clinic. David, a patient with advanced multiple myeloma, was off pain medication after one week of treatment. George, a patient with multiple sclerosis, regained balance after one week of treatment. The immune system of a...

  • Oral medications for relapsing-remitting MS.  // Travel Medicine Advisor;Mar2010 Supplement, p1 

    The article offers several updates in the field of medicine. The "New England Journal of Medicine" published studies which reveal that fingolimod and cladribine are both effective oral treatments for relapsing-remitting multiple sclerosis (MS). Study shows that antihypertension drugs are...

  • MS14, a Marine Herbal Medicine, an Immunosuppressive Drug in Experimental Autoimmune Encephalomyelitis. Kalan, Abbas Ebrahimi; Rad, Jafar Soleimani; Kafami, Laya; Mohamadnezhad, Daryoush; Khaki, Amir Afshin; Roushandeh, Amaneh Mohammadi // Iranian Red Crescent Medical Journal;Jun2014, Vol. 16 Issue 7, p1 

    Background: Cytokines are secreted signaling proteins which play essential roles in immune responses during experimental autoimmune encephalomyelitis (EAE), a demyelinating model that mimics many features of multiple sclerosis (MS). Interleukin 6 (IL-6) is a multifunctional cytokine produced by...

  • Multiple sclerosis, cognitive dysfunction and the potential benefits of exercise. Feinstein, Anthony // Multiple Sclerosis Journal;Sep2011, Vol. 17 Issue 9, p1032 

    The author reflects on the benefit of exercise on cognitive dysfunction, which affects patients with multiple sclerosis (MS). He mentions that based on the results of randomized controlled trials (CTs), exercise training proved to cause cognitive improvement in older adults with dementia. He...

  • Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis. Mangano, K.; Nicoletti, A.; Patti, F. // Current Medical Literature: Multiple Sclerosis;2010, Vol. 2 Issue 2, p55 

    In this article the author discusses the study by K. Mangano and colleagues on the use of cyclophosphamide in experimental autoimmune encephalomyelitis (EAE) in Dark-Agouti rats. The author cites that cyclophosphamide may have potential use in multiple sclerosis (MS) as Mangano's study reveals...

  • Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Sumowski, J. F.; Wylie, G. R.; Deluca, J. // Current Medical Literature: Multiple Sclerosis;2010, Vol. 2 Issue 2, p58 

    In this article the author focuses on a study which implies that intellectual development alleviates the impact cognitive decline due to neuropathological diseases like multiple sclerosis (MS). The author notes that the correlation between cognitive reserve network shows that patients with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics